BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 51155328 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(Oc3ccccc3)cc12 |wU:3.2,wD:5.7,(11.39,-13.98,;12.4,-12.84,;13.91,-13.14,;11.92,-11.37,;10.55,-10.69,;11.23,-9.32,;12.61,-9.99,;10.76,-7.85,;11.65,-6.6,;10.74,-5.35,;9.27,-5.84,;7.94,-5.07,;6.61,-5.86,;6.61,-7.4,;5.27,-8.17,;5.27,-9.71,;6.6,-10.46,;6.61,-12,;5.27,-12.79,;3.93,-12,;3.94,-10.46,;7.94,-8.17,;9.29,-7.38,)| InChI=1S/C20H22N2O/c1-22(2)15-10-14(11-15)19-13-21-20-9-8-17(12-18(19)20)23-16-6-4-3-5-7-16/h3-9,12-15,21H,10-11H2,1-2H3 JWPZJMPAUVKYCC-UHFFFAOYSA-N 50473501 CHEMBL2368253 5-hydroxytryptamine receptor 1B Homo sapiens 98 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473501 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473501&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 10494885 433940766 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155329 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(cc12)C(=O)NCc1ccccc1 |wU:5.7,wD:3.2,(17.75,-10.38,;16.25,-10.05,;15.22,-11.22,;15.76,-8.61,;16.46,-7.23,;15.08,-6.53,;14.38,-7.91,;14.59,-5.09,;15.5,-3.83,;14.59,-2.59,;13.13,-3.08,;11.79,-2.31,;10.46,-3.08,;10.46,-4.62,;11.79,-5.39,;13.13,-4.62,;9.12,-5.39,;7.79,-4.62,;9.12,-6.93,;7.79,-7.7,;7.79,-9.23,;9.12,-10,;9.12,-11.52,;7.79,-12.31,;6.45,-11.54,;6.46,-10,)| InChI=1S/C22H25N3O/c1-25(2)18-10-17(11-18)20-14-23-21-9-8-16(12-19(20)21)22(26)24-13-15-6-4-3-5-7-15/h3-9,12,14,17-18,23H,10-11,13H2,1-2H3,(H,24,26) GCMJIDLORVWRLW-UHFFFAOYSA-N 50473502 CHEMBL159470 5-hydroxytryptamine receptor 1D Homo sapiens 141 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473502 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473502&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 10617665 433940767 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155330 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC3COC(=O)N3)cc12 |wU:3.2,wD:5.7,(12.22,-9.08,;13.25,-7.93,;14.76,-8.24,;12.76,-6.47,;11.38,-5.77,;12.08,-4.41,;13.46,-5.09,;11.59,-2.95,;12.5,-1.69,;11.59,-.45,;10.13,-.94,;8.79,-.17,;7.46,-.94,;7.46,-2.48,;6.12,-3.25,;6.12,-4.79,;4.88,-5.7,;5.36,-7.16,;6.9,-7.17,;7.98,-8.25,;7.37,-5.7,;8.79,-3.25,;10.13,-2.48,)| InChI=1S/C18H23N3O2/c1-21(2)14-7-12(8-14)16-9-19-17-4-3-11(6-15(16)17)5-13-10-23-18(22)20-13/h3-4,6,9,12-14,19H,5,7-8,10H2,1-2H3,(H,20,22) JLDUTSKKXXJGGG-UHFFFAOYSA-N 50473503 CHEMBL2110300 5-hydroxytryptamine receptor 1B Homo sapiens 112 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473503 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473503&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 18366015 433940768 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155331 CN(C)[C@H]1C[C@H](Cc2c[nH]c3ccc(C[C@H]4COC(=O)N4)cc23)C1 |wU:3.2,wD:5.5,15.14,(19.87,-5.25,;19.38,-3.78,;20.41,-2.63,;17.88,-3.47,;16.6,-4.31,;15.76,-3.03,;14.25,-2.71,;13.76,-1.26,;14.67,-.01,;13.75,1.24,;12.29,.75,;10.96,1.52,;9.63,.74,;9.63,-.8,;8.28,-1.57,;8.28,-3.11,;7.05,-4.01,;7.53,-5.48,;9.07,-5.48,;10.15,-6.56,;9.54,-4.01,;10.96,-1.57,;12.29,-.79,;17.04,-2.18,)| InChI=1S/C19H25N3O2/c1-22(2)16-7-13(8-16)5-14-10-20-18-4-3-12(9-17(14)18)6-15-11-24-19(23)21-15/h3-4,9-10,13,15-16,20H,5-8,11H2,1-2H3,(H,21,23) OAEYRCBANJKSPM-UHFFFAOYSA-N 50473504 CHEMBL3084967 5-hydroxytryptamine receptor 1B Homo sapiens 141 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473504 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473504&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 10592324 433940769 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155332 CN[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC3COC(=O)N3)cc12 |wU:2.1,wD:4.6,(17.04,-8.2,;15.54,-7.89,;15.06,-6.42,;13.68,-5.72,;14.37,-4.36,;15.75,-5.05,;13.89,-2.9,;14.79,-1.64,;13.87,-.4,;12.41,-.89,;11.07,-.12,;9.74,-.89,;9.74,-2.43,;8.41,-3.2,;8.41,-4.74,;7.17,-5.65,;7.64,-7.12,;9.18,-7.12,;10.27,-8.21,;9.66,-5.65,;11.07,-3.2,;12.42,-2.43,)| InChI=1S/C17H21N3O2/c1-18-12-6-11(7-12)15-8-19-16-3-2-10(5-14(15)16)4-13-9-22-17(21)20-13/h2-3,5,8,11-13,18-19H,4,6-7,9H2,1H3,(H,20,21) VHUSWFDFXAXWRN-UHFFFAOYSA-N 50473505 CHEMBL2368256 5-hydroxytryptamine receptor 1D Homo sapiens 7.1 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473505 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473505&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 18691566 433940770 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155333 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(Cc3nc(C)no3)cc12 |wU:5.7,wD:3.2,(17.25,-10.91,;15.75,-10.6,;14.73,-11.75,;15.26,-9.14,;15.96,-7.77,;14.59,-7.08,;13.89,-8.46,;14.1,-5.62,;15.01,-4.38,;14.08,-3.13,;12.63,-3.62,;11.29,-2.85,;9.96,-3.63,;9.96,-5.17,;8.62,-5.94,;8.62,-7.46,;7.39,-8.37,;7.86,-9.84,;6.95,-11.09,;9.4,-9.84,;9.88,-8.37,;11.29,-5.94,;12.63,-5.16,)| InChI=1S/C18H22N4O/c1-11-20-18(23-21-11)7-12-4-5-17-15(6-12)16(10-19-17)13-8-14(9-13)22(2)3/h4-6,10,13-14,19H,7-9H2,1-3H3 OLBCZDIVUFQNTI-UHFFFAOYSA-N 50473506 CHEMBL161694 5-hydroxytryptamine receptor 1D Homo sapiens 933 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473506 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473506&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 10757342 433940771 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155334 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CCN3C(=O)NC(C)(C)C3=O)cc12 |wU:3.2,wD:5.7,(14.1,-12.47,;15.13,-11.32,;16.64,-11.63,;14.64,-9.85,;13.26,-9.15,;13.96,-7.79,;15.34,-8.48,;13.47,-6.33,;14.38,-5.07,;13.46,-3.83,;12,-4.32,;10.66,-3.55,;9.33,-4.32,;9.33,-5.86,;7.99,-6.63,;7.99,-8.17,;9.33,-8.94,;10.74,-8.33,;11.2,-7.4,;11.77,-9.47,;11,-10.8,;10.59,-12.28,;12.33,-11.57,;9.5,-10.48,;8.69,-11.53,;10.66,-6.63,;12,-5.86,)| InChI=1S/C21H28N4O2/c1-21(2)19(26)25(20(27)23-21)8-7-13-5-6-18-16(9-13)17(12-22-18)14-10-15(11-14)24(3)4/h5-6,9,12,14-15,22H,7-8,10-11H2,1-4H3,(H,23,27) VUTRHRVGOKNTJD-UHFFFAOYSA-N 50473507 CHEMBL2368262 5-hydroxytryptamine receptor 1B Homo sapiens 1202 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473507 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473507&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 10714071 433940772 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155335 CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1 InChI=1S/C14H21N3O2S/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3/h4-5,8-9,15-16H,6-7,10H2,1-3H3 KQKPFRSPSRPDEB-UHFFFAOYSA-N 50005835 Sumax::3-[2-(dimethylamino)ethyl]-N-methylindole-5-methanesulfonamide::1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide::Sumatran::1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide::CHEMBL128::3-(2-(dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide::(3-[2-(dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide::SUMATRIPTAN 5-hydroxytryptamine receptor 1B Homo sapiens 0.501187 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50005835 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50005835&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 5358 103919260 CHEMBL128 DB00669 C07319 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155336 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC3COC(=O)N3)cc12 |wU:3.2,wD:5.7,(12.22,-9.08,;13.25,-7.93,;14.76,-8.24,;12.76,-6.47,;11.38,-5.77,;12.08,-4.41,;13.46,-5.09,;11.59,-2.95,;12.5,-1.69,;11.59,-.45,;10.13,-.94,;8.79,-.17,;7.46,-.94,;7.46,-2.48,;6.12,-3.25,;6.12,-4.79,;4.88,-5.7,;5.36,-7.16,;6.9,-7.17,;7.98,-8.25,;7.37,-5.7,;8.79,-3.25,;10.13,-2.48,)| InChI=1S/C18H23N3O2/c1-21(2)14-7-12(8-14)16-9-19-17-4-3-11(6-15(16)17)5-13-10-23-18(22)20-13/h3-4,6,9,12-14,19H,5,7-8,10H2,1-2H3,(H,20,22) JLDUTSKKXXJGGG-UHFFFAOYSA-N 50473503 CHEMBL2110300 5-hydroxytryptamine receptor 1A Homo sapiens 3548 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473503 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=493&target=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473503&enzyme=5-hydroxytryptamine+receptor+1A&column=ki&startPg=0&Increment=50&submit=Search 18366015 433940768 1 MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTLIFCAVLGNACVVAAIALERSLQNVANYLIGSLAVTDLMVSVLVLPMAALYQVLNKWTLGQVTCDLFIALDVLCCTSSILHLCAIALDRYWAITDPIDYVNKRTPRRAAALISLTWLIGFLISIPPMLGWRTPEDRSDPDACTISKDHGYTIYSTFGAFYIPLLLMLVLYGRIFRAARFRIRKTVKKVEKTGADTRHGASPAPQPKKSVNGESGSRNWRLGVESKAGGALCANGAVRQGDDGAALEVIEVHRVGNSKEHLPLPSEAGPTPCAPASFERKNERNAEAKRKMALARERKTVKTLGIIMGTFILCWLPFFIVALVLPFCESSCHMPTLLGAIINWLGYSNSLLNPVIYAYFNKDFQNAFKKIIKCKFCRQ 5-hydroxytryptamine receptor 1A 5HT1A_HUMAN P08908 Q6LAE7 51155337 CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1 InChI=1S/C14H21N3O2S/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3/h4-5,8-9,15-16H,6-7,10H2,1-3H3 KQKPFRSPSRPDEB-UHFFFAOYSA-N 50005835 Sumax::3-[2-(dimethylamino)ethyl]-N-methylindole-5-methanesulfonamide::1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide::Sumatran::1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide::CHEMBL128::3-(2-(dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide::(3-[2-(dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide::SUMATRIPTAN 5-hydroxytryptamine receptor 1D Homo sapiens 3.0 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50005835 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50005835&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 5358 103919260 CHEMBL128 DB00669 C07319 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155338 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(cc12)C(N)=O |wU:5.7,wD:3.2,(14.61,-11.78,;15.62,-10.62,;17.13,-10.94,;15.14,-9.17,;15.83,-7.79,;14.45,-7.1,;13.77,-8.47,;13.98,-5.65,;14.87,-4.39,;13.96,-3.15,;12.49,-3.64,;11.16,-2.87,;9.83,-3.64,;9.83,-5.18,;11.16,-5.95,;12.51,-5.18,;8.49,-5.95,;8.49,-7.47,;7.16,-5.18,)| InChI=1S/C15H19N3O/c1-18(2)11-5-10(6-11)13-8-17-14-4-3-9(15(16)19)7-12(13)14/h3-4,7-8,10-11,17H,5-6H2,1-2H3,(H2,16,19) WHLKSQOCYRUNEX-UHFFFAOYSA-N 50473508 CHEMBL158638 5-hydroxytryptamine receptor 1D Homo sapiens 15 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473508 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473508&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 10539089 433940773 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155339 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(Cc3nc(C)no3)cc12 |wU:5.7,wD:3.2,(17.25,-10.91,;15.75,-10.6,;14.73,-11.75,;15.26,-9.14,;15.96,-7.77,;14.59,-7.08,;13.89,-8.46,;14.1,-5.62,;15.01,-4.38,;14.08,-3.13,;12.63,-3.62,;11.29,-2.85,;9.96,-3.63,;9.96,-5.17,;8.62,-5.94,;8.62,-7.46,;7.39,-8.37,;7.86,-9.84,;6.95,-11.09,;9.4,-9.84,;9.88,-8.37,;11.29,-5.94,;12.63,-5.16,)| InChI=1S/C18H22N4O/c1-11-20-18(23-21-11)7-12-4-5-17-15(6-12)16(10-19-17)13-8-14(9-13)22(2)3/h4-6,10,13-14,19H,7-9H2,1-3H3 OLBCZDIVUFQNTI-UHFFFAOYSA-N 50473506 CHEMBL161694 5-hydroxytryptamine receptor 1B Homo sapiens 1514 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473506 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473506&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 10757342 433940771 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155340 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC3COC(=O)N3C)cc12 |wU:3.2,wD:5.7,(17.55,-9.96,;18.56,-8.8,;20.07,-9.12,;18.08,-7.35,;16.71,-6.66,;17.39,-5.28,;18.77,-5.97,;16.92,-3.83,;17.81,-2.57,;16.9,-1.33,;15.43,-1.82,;14.1,-1.05,;12.77,-1.83,;12.77,-3.37,;11.43,-4.14,;11.43,-5.68,;10.2,-6.58,;10.67,-8.05,;12.21,-8.05,;13.3,-9.13,;12.68,-6.58,;14.22,-6.58,;14.1,-4.14,;15.45,-3.36,)| InChI=1S/C19H25N3O2/c1-21(2)14-8-13(9-14)17-10-20-18-5-4-12(7-16(17)18)6-15-11-24-19(23)22(15)3/h4-5,7,10,13-15,20H,6,8-9,11H2,1-3H3 SLYXECCOYYLQHN-UHFFFAOYSA-N 50473509 CHEMBL2368257 5-hydroxytryptamine receptor 1B Homo sapiens 97.7 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473509 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473509&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 18691565 433940774 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155341 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC3COC(=O)N3)cc12 |wU:3.2,wD:5.7,(12.22,-9.08,;13.25,-7.93,;14.76,-8.24,;12.76,-6.47,;11.38,-5.77,;12.08,-4.41,;13.46,-5.09,;11.59,-2.95,;12.5,-1.69,;11.59,-.45,;10.13,-.94,;8.79,-.17,;7.46,-.94,;7.46,-2.48,;6.12,-3.25,;6.12,-4.79,;4.88,-5.7,;5.36,-7.16,;6.9,-7.17,;7.98,-8.25,;7.37,-5.7,;8.79,-3.25,;10.13,-2.48,)| InChI=1S/C18H23N3O2/c1-21(2)14-7-12(8-14)16-9-19-17-4-3-11(6-15(16)17)5-13-10-23-18(22)20-13/h3-4,6,9,12-14,19H,5,7-8,10H2,1-2H3,(H,20,22) JLDUTSKKXXJGGG-UHFFFAOYSA-N 50473503 CHEMBL2110300 5-hydroxytryptamine receptor 1D Homo sapiens 100 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473503 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473503&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 18366015 433940768 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155342 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC3COC(=O)N3)cc12 |wU:3.2,wD:5.7,(12.22,-9.08,;13.25,-7.93,;14.76,-8.24,;12.76,-6.47,;11.38,-5.77,;12.08,-4.41,;13.46,-5.09,;11.59,-2.95,;12.5,-1.69,;11.59,-.45,;10.13,-.94,;8.79,-.17,;7.46,-.94,;7.46,-2.48,;6.12,-3.25,;6.12,-4.79,;4.88,-5.7,;5.36,-7.16,;6.9,-7.17,;7.98,-8.25,;7.37,-5.7,;8.79,-3.25,;10.13,-2.48,)| InChI=1S/C18H23N3O2/c1-21(2)14-7-12(8-14)16-9-19-17-4-3-11(6-15(16)17)5-13-10-23-18(22)20-13/h3-4,6,9,12-14,19H,5,7-8,10H2,1-2H3,(H,20,22) JLDUTSKKXXJGGG-UHFFFAOYSA-N 50473503 CHEMBL2110300 5-hydroxytryptamine receptor 1D Homo sapiens 15.8 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473503 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473503&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 18366015 433940768 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155343 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CCN3C(=O)c4ccccc4C3=O)cc12 |wU:3.2,wD:5.7,(14.1,-12.47,;15.13,-11.32,;16.64,-11.63,;14.64,-9.85,;13.26,-9.15,;13.96,-7.79,;15.34,-8.48,;13.47,-6.33,;14.38,-5.07,;13.46,-3.83,;12,-4.32,;10.66,-3.55,;9.33,-4.32,;9.33,-5.86,;7.99,-6.63,;7.99,-8.17,;6.66,-8.94,;6.49,-10.48,;7.64,-11.51,;4.99,-10.8,;4.23,-12.12,;2.69,-12.13,;1.92,-10.79,;2.69,-9.46,;4.23,-9.47,;5.26,-8.31,;4.93,-6.82,;10.66,-6.63,;12,-5.86,)| InChI=1S/C24H25N3O2/c1-26(2)17-12-16(13-17)21-14-25-22-8-7-15(11-20(21)22)9-10-27-23(28)18-5-3-4-6-19(18)24(27)29/h3-8,11,14,16-17,25H,9-10,12-13H2,1-2H3 DMYDUXUHAJAUDX-UHFFFAOYSA-N 50473510 CHEMBL2368261 5-hydroxytryptamine receptor 1B Homo sapiens 204 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473510 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473510&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 10643940 433940775 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155344 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(Cc3n[nH]c(C)n3)cc12 |wU:5.7,wD:3.2,(17.25,-10.91,;15.75,-10.6,;14.73,-11.75,;15.26,-9.14,;15.96,-7.77,;14.59,-7.08,;13.89,-8.46,;14.1,-5.62,;15.01,-4.38,;14.08,-3.13,;12.63,-3.62,;11.29,-2.85,;9.96,-3.63,;9.96,-5.17,;8.62,-5.94,;8.62,-7.46,;9.88,-8.37,;9.4,-9.84,;7.86,-9.84,;6.95,-11.09,;7.39,-8.37,;11.29,-5.94,;12.63,-5.16,)| InChI=1S/C18H23N5/c1-11-20-18(22-21-11)7-12-4-5-17-15(6-12)16(10-19-17)13-8-14(9-13)23(2)3/h4-6,10,13-14,19H,7-9H2,1-3H3,(H,20,21,22) PASVZMRRFAPOKE-UHFFFAOYSA-N 50473511 CHEMBL159536 5-hydroxytryptamine receptor 1D Homo sapiens 2042 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473511 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473511&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 10852406 433940776 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155345 N[C@H]1C[C@@H](C1)c1c[nH]c2ccc(Oc3ccccc3)cc12 |wU:1.0,wD:3.5,(12.4,-12.84,;11.92,-11.37,;10.55,-10.69,;11.23,-9.32,;12.61,-9.99,;10.76,-7.85,;11.65,-6.6,;10.74,-5.35,;9.27,-5.84,;7.94,-5.07,;6.61,-5.86,;6.61,-7.4,;5.27,-8.17,;5.27,-9.71,;6.6,-10.46,;6.61,-12,;5.27,-12.79,;3.93,-12,;3.94,-10.46,;7.94,-8.17,;9.29,-7.38,)| InChI=1S/C18H18N2O/c19-13-8-12(9-13)17-11-20-18-7-6-15(10-16(17)18)21-14-4-2-1-3-5-14/h1-7,10-13,20H,8-9,19H2 KUJBWNONBWTAMM-UHFFFAOYSA-N 50473512 CHEMBL2368254 5-hydroxytryptamine receptor 1D Homo sapiens 14 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473512 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473512&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 10588665 433940777 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155346 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC(=O)NCc3ccccc3)cc12 |wU:5.7,wD:3.2,(10.69,-8.83,;11.7,-7.68,;13.21,-7.99,;11.22,-6.21,;11.91,-4.84,;10.53,-4.15,;9.85,-5.53,;10.06,-2.69,;10.95,-1.45,;10.04,-.19,;8.57,-.68,;7.24,.09,;5.91,-.7,;5.91,-2.24,;4.56,-3.01,;4.56,-4.55,;5.91,-5.32,;3.24,-5.32,;3.24,-6.86,;1.9,-7.63,;1.91,-9.15,;.58,-9.92,;-.76,-9.15,;-.76,-7.59,;.57,-6.84,;7.24,-3.01,;8.59,-2.22,)| InChI=1S/C23H27N3O/c1-26(2)19-12-18(13-19)21-15-24-22-9-8-17(10-20(21)22)11-23(27)25-14-16-6-4-3-5-7-16/h3-10,15,18-19,24H,11-14H2,1-2H3,(H,25,27) HAELKXOQQMRYKK-UHFFFAOYSA-N 50473513 CHEMBL350277 5-hydroxytryptamine receptor 1B Homo sapiens 263 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473513 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473513&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 10546537 433940778 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155347 CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12 InChI=1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20) ULSDMUVEXKOYBU-UHFFFAOYSA-N 50033383 (S)-4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)oxazolidin-2-one::(S)-4-[3-(2-Dimethylamino-ethyl)-1H-indol-5-ylmethyl]-oxazolidin-2-one::311C90::CHEMBL1185::ZOMIG::ZOMIG-ZMT::ZOLMITRIPTAN 5-hydroxytryptamine receptor 1D Homo sapiens 2.8 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50033383 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50033383&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 60857 103941674 CHEMBL1185 DB00315 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155348 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CN3C(=O)NC(C)(C)C3=O)cc12 |wU:3.2,wD:5.7,(4.42,-3.82,;5.43,-2.68,;6.93,-2.98,;4.95,-1.21,;3.58,-.52,;4.25,.84,;5.64,.16,;3.79,2.31,;4.67,3.56,;3.76,4.82,;2.31,4.31,;.96,5.08,;-.37,4.31,;-.37,2.77,;-1.69,2,;-1.69,.47,;-.46,-.47,;.58,-.4,;-.96,-1.92,;-2.5,-1.9,;-3.99,-2.29,;-2.1,-3.38,;-2.95,-.4,;-4.26,-.23,;.96,2,;2.32,2.78,)| InChI=1S/C20H26N4O2/c1-20(2)18(25)24(19(26)22-20)11-12-5-6-17-15(7-12)16(10-21-17)13-8-14(9-13)23(3)4/h5-7,10,13-14,21H,8-9,11H2,1-4H3,(H,22,26) QRVMHQDXGODYND-UHFFFAOYSA-N 50473514 CHEMBL2368260 5-hydroxytryptamine receptor 1B Homo sapiens 3802 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473514 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473514&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 10665840 433940779 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155349 CC1(C)NC(=O)N(CCc2ccc3[nH]cc([C@H]4C[C@H](N)C4)c3c2)C1=O |wU:18.18,wD:16.15,(10.59,-12.28,;11,-10.8,;12.33,-11.57,;11.77,-9.47,;10.74,-8.33,;11.2,-7.4,;9.33,-8.94,;7.99,-8.17,;7.99,-6.63,;9.33,-5.86,;9.33,-4.32,;10.66,-3.55,;12,-4.32,;13.46,-3.83,;14.38,-5.07,;13.47,-6.33,;13.96,-7.79,;13.26,-9.15,;14.64,-9.85,;15.13,-11.32,;15.34,-8.48,;12,-5.86,;10.66,-6.63,;9.5,-10.48,;8.69,-11.53,)| InChI=1S/C19H24N4O2/c1-19(2)17(24)23(18(25)22-19)6-5-11-3-4-16-14(7-11)15(10-21-16)12-8-13(20)9-12/h3-4,7,10,12-13,21H,5-6,8-9,20H2,1-2H3,(H,22,25) YKKNEWJGMYTISV-UHFFFAOYSA-N 50473515 CHEMBL2368255 5-hydroxytryptamine receptor 1B Homo sapiens 1122 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473515 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473515&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 10664878 433940780 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155350 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(cc12)C(=O)NCc1ccccc1 |wU:5.7,wD:3.2,(17.75,-10.38,;16.25,-10.05,;15.22,-11.22,;15.76,-8.61,;16.46,-7.23,;15.08,-6.53,;14.38,-7.91,;14.59,-5.09,;15.5,-3.83,;14.59,-2.59,;13.13,-3.08,;11.79,-2.31,;10.46,-3.08,;10.46,-4.62,;11.79,-5.39,;13.13,-4.62,;9.12,-5.39,;7.79,-4.62,;9.12,-6.93,;7.79,-7.7,;7.79,-9.23,;9.12,-10,;9.12,-11.52,;7.79,-12.31,;6.45,-11.54,;6.46,-10,)| InChI=1S/C22H25N3O/c1-25(2)18-10-17(11-18)20-14-23-21-9-8-16(12-19(20)21)22(26)24-13-15-6-4-3-5-7-15/h3-9,12,14,17-18,23H,10-11,13H2,1-2H3,(H,24,26) GCMJIDLORVWRLW-UHFFFAOYSA-N 50473502 CHEMBL159470 5-hydroxytryptamine receptor 1B Homo sapiens 316 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473502 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473502&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 10617665 433940767 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155351 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CCN3C(=O)NC(C)(C)C3=O)cc12 |wU:3.2,wD:5.7,(14.1,-12.47,;15.13,-11.32,;16.64,-11.63,;14.64,-9.85,;13.26,-9.15,;13.96,-7.79,;15.34,-8.48,;13.47,-6.33,;14.38,-5.07,;13.46,-3.83,;12,-4.32,;10.66,-3.55,;9.33,-4.32,;9.33,-5.86,;7.99,-6.63,;7.99,-8.17,;9.33,-8.94,;10.74,-8.33,;11.2,-7.4,;11.77,-9.47,;11,-10.8,;10.59,-12.28,;12.33,-11.57,;9.5,-10.48,;8.69,-11.53,;10.66,-6.63,;12,-5.86,)| InChI=1S/C21H28N4O2/c1-21(2)19(26)25(20(27)23-21)8-7-13-5-6-18-16(9-13)17(12-22-18)14-10-15(11-14)24(3)4/h5-6,9,12,14-15,22H,7-8,10-11H2,1-4H3,(H,23,27) VUTRHRVGOKNTJD-UHFFFAOYSA-N 50473507 CHEMBL2368262 5-hydroxytryptamine receptor 1D Homo sapiens 1479 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473507 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473507&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 10714071 433940772 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155352 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC3COC(=O)N3)cc12 |wU:3.2,wD:5.7,(12.22,-9.08,;13.25,-7.93,;14.76,-8.24,;12.76,-6.47,;11.38,-5.77,;12.08,-4.41,;13.46,-5.09,;11.59,-2.95,;12.5,-1.69,;11.59,-.45,;10.13,-.94,;8.79,-.17,;7.46,-.94,;7.46,-2.48,;6.12,-3.25,;6.12,-4.79,;4.88,-5.7,;5.36,-7.16,;6.9,-7.17,;7.98,-8.25,;7.37,-5.7,;8.79,-3.25,;10.13,-2.48,)| InChI=1S/C18H23N3O2/c1-21(2)14-7-12(8-14)16-9-19-17-4-3-11(6-15(16)17)5-13-10-23-18(22)20-13/h3-4,6,9,12-14,19H,5,7-8,10H2,1-2H3,(H,20,22) JLDUTSKKXXJGGG-UHFFFAOYSA-N 50473503 CHEMBL2110300 5-hydroxytryptamine receptor 1D Homo sapiens 100.0 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473503 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473503&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 18366015 433940768 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155353 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC3COC(=O)N3C)cc12 |wU:3.2,wD:5.7,(17.55,-9.96,;18.56,-8.8,;20.07,-9.12,;18.08,-7.35,;16.71,-6.66,;17.39,-5.28,;18.77,-5.97,;16.92,-3.83,;17.81,-2.57,;16.9,-1.33,;15.43,-1.82,;14.1,-1.05,;12.77,-1.83,;12.77,-3.37,;11.43,-4.14,;11.43,-5.68,;10.2,-6.58,;10.67,-8.05,;12.21,-8.05,;13.3,-9.13,;12.68,-6.58,;14.22,-6.58,;14.1,-4.14,;15.45,-3.36,)| InChI=1S/C19H25N3O2/c1-21(2)14-8-13(9-14)17-10-20-18-5-4-12(7-16(17)18)6-15-11-24-19(23)22(15)3/h4-5,7,10,13-15,20H,6,8-9,11H2,1-3H3 SLYXECCOYYLQHN-UHFFFAOYSA-N 50473509 CHEMBL2368257 5-hydroxytryptamine receptor 1D Homo sapiens 58 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473509 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473509&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 18691565 433940774 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155354 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CN3C(=O)NC(C)(C)C3=O)cc12 |wU:3.2,wD:5.7,(4.42,-3.82,;5.43,-2.68,;6.93,-2.98,;4.95,-1.21,;3.58,-.52,;4.25,.84,;5.64,.16,;3.79,2.31,;4.67,3.56,;3.76,4.82,;2.31,4.31,;.96,5.08,;-.37,4.31,;-.37,2.77,;-1.69,2,;-1.69,.47,;-.46,-.47,;.58,-.4,;-.96,-1.92,;-2.5,-1.9,;-3.99,-2.29,;-2.1,-3.38,;-2.95,-.4,;-4.26,-.23,;.96,2,;2.32,2.78,)| InChI=1S/C20H26N4O2/c1-20(2)18(25)24(19(26)22-20)11-12-5-6-17-15(7-12)16(10-21-17)13-8-14(9-13)23(3)4/h5-7,10,13-14,21H,8-9,11H2,1-4H3,(H,22,26) QRVMHQDXGODYND-UHFFFAOYSA-N 50473514 CHEMBL2368260 5-hydroxytryptamine receptor 1D Homo sapiens 3090 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473514 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473514&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 10665840 433940779 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155355 N[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC3COC(=O)N3)cc12 |wU:1.0,wD:3.5,(17.46,-8.49,;16.99,-7.03,;15.61,-6.33,;16.29,-4.97,;17.67,-5.65,;15.82,-3.51,;16.71,-2.25,;15.8,-1.01,;14.33,-1.5,;13,-.73,;11.67,-1.5,;11.67,-3.04,;10.34,-3.81,;10.34,-5.35,;9.1,-6.26,;9.57,-7.71,;11.11,-7.73,;12.2,-8.82,;11.58,-6.26,;13,-3.81,;14.35,-3.04,)| InChI=1S/C16H19N3O2/c17-11-5-10(6-11)14-7-18-15-2-1-9(4-13(14)15)3-12-8-21-16(20)19-12/h1-2,4,7,10-12,18H,3,5-6,8,17H2,(H,19,20) ITXICYVPEAFHQO-UHFFFAOYSA-N 50473516 CHEMBL2110299 5-hydroxytryptamine receptor 1B Homo sapiens 18 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473516 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473516&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 18691541 433940781 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155356 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC(N)=O)cc12 |wU:5.7,wD:3.2,(12.37,-11.41,;10.85,-11.09,;9.83,-12.25,;10.37,-9.64,;11.06,-8.26,;9.68,-7.57,;8.99,-8.94,;9.2,-6.11,;10.1,-4.85,;9.19,-3.62,;7.72,-4.11,;6.39,-3.34,;5.06,-4.11,;5.06,-5.65,;3.72,-6.42,;3.72,-7.94,;2.39,-8.73,;5.06,-8.73,;6.39,-6.42,;7.73,-5.65,)| InChI=1S/C16H21N3O/c1-19(2)12-7-11(8-12)14-9-18-15-4-3-10(5-13(14)15)6-16(17)20/h3-5,9,11-12,18H,6-8H2,1-2H3,(H2,17,20) ABNIHDGJNQLJKY-UHFFFAOYSA-N 50473517 CHEMBL348811 5-hydroxytryptamine receptor 1B Homo sapiens 1349 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473517 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473517&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 10612178 433940782 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155357 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(Oc3ccccc3)cc12 |wU:3.2,wD:5.7,(11.39,-13.98,;12.4,-12.84,;13.91,-13.14,;11.92,-11.37,;10.55,-10.69,;11.23,-9.32,;12.61,-9.99,;10.76,-7.85,;11.65,-6.6,;10.74,-5.35,;9.27,-5.84,;7.94,-5.07,;6.61,-5.86,;6.61,-7.4,;5.27,-8.17,;5.27,-9.71,;6.6,-10.46,;6.61,-12,;5.27,-12.79,;3.93,-12,;3.94,-10.46,;7.94,-8.17,;9.29,-7.38,)| InChI=1S/C20H22N2O/c1-22(2)15-10-14(11-15)19-13-21-20-9-8-17(12-18(19)20)23-16-6-4-3-5-7-16/h3-9,12-15,21H,10-11H2,1-2H3 JWPZJMPAUVKYCC-UHFFFAOYSA-N 50473501 CHEMBL2368253 5-hydroxytryptamine receptor 1D Homo sapiens 65 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473501 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473501&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 10494885 433940766 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155358 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC3COC(=O)N3)cc12 |wU:3.2,wD:5.7,(12.22,-9.08,;13.25,-7.93,;14.76,-8.24,;12.76,-6.47,;11.38,-5.77,;12.08,-4.41,;13.46,-5.09,;11.59,-2.95,;12.5,-1.69,;11.59,-.45,;10.13,-.94,;8.79,-.17,;7.46,-.94,;7.46,-2.48,;6.12,-3.25,;6.12,-4.79,;4.88,-5.7,;5.36,-7.16,;6.9,-7.17,;7.98,-8.25,;7.37,-5.7,;8.79,-3.25,;10.13,-2.48,)| InChI=1S/C18H23N3O2/c1-21(2)14-7-12(8-14)16-9-19-17-4-3-11(6-15(16)17)5-13-10-23-18(22)20-13/h3-4,6,9,12-14,19H,5,7-8,10H2,1-2H3,(H,20,22) JLDUTSKKXXJGGG-UHFFFAOYSA-N 50473503 CHEMBL2110300 5-hydroxytryptamine receptor 1F Homo sapiens 363 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473503 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=49000035&target=5-hydroxytryptamine+receptor+1F&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473503&enzyme=5-hydroxytryptamine+receptor+1F&column=ki&startPg=0&Increment=50&submit=Search 18366015 433940768 1 MDFLNSSDQNLTSEELLNRMPSKILVSLTLSGLALMTTTINSLVIAAIIVTRKLHHPANYLICSLAVTDFLVAVLVMPFSIVYIVRESWIMGQVVCDIWLSVDITCCTCSILHLSAIALDRYRAITDAVEYARKRTPKHAGIMITIVWIISVFISMPPLFWRHQGTSRDDECIIKHDHIVSTIYSTFGAFYIPLALILILYYKIYRAAKTLYHKRQASRIAKEEVNGQVLLESGEKSTKSVSTSYVLEKSLSDPSTDFDKIHSTVRSLRSEFKHEKSWRRQKISGTRERKAATTLGLILGAFVICWLPFFVKELVVNVCDKCKISEEMSNFLAWLGYLNSLINPLIYTIFNEDFKKAFQKLVRCRC 7EXD 5-hydroxytryptamine receptor 1F 5HT1F_HUMAN P30939 51155359 CC1(C)NC(=O)N(CCc2ccc3[nH]cc([C@H]4C[C@H](N)C4)c3c2)C1=O |wU:18.18,wD:16.15,(10.59,-12.28,;11,-10.8,;12.33,-11.57,;11.77,-9.47,;10.74,-8.33,;11.2,-7.4,;9.33,-8.94,;7.99,-8.17,;7.99,-6.63,;9.33,-5.86,;9.33,-4.32,;10.66,-3.55,;12,-4.32,;13.46,-3.83,;14.38,-5.07,;13.47,-6.33,;13.96,-7.79,;13.26,-9.15,;14.64,-9.85,;15.13,-11.32,;15.34,-8.48,;12,-5.86,;10.66,-6.63,;9.5,-10.48,;8.69,-11.53,)| InChI=1S/C19H24N4O2/c1-19(2)17(24)23(18(25)22-19)6-5-11-3-4-16-14(7-11)15(10-21-16)12-8-13(20)9-12/h3-4,7,10,12-13,21H,5-6,8-9,20H2,1-2H3,(H,22,25) YKKNEWJGMYTISV-UHFFFAOYSA-N 50473515 CHEMBL2368255 5-hydroxytryptamine receptor 1D Homo sapiens 501 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473515 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473515&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 10664878 433940780 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155360 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC3COC(=O)N3)cc12 |wU:3.2,wD:5.7,(12.22,-9.08,;13.25,-7.93,;14.76,-8.24,;12.76,-6.47,;11.38,-5.77,;12.08,-4.41,;13.46,-5.09,;11.59,-2.95,;12.5,-1.69,;11.59,-.45,;10.13,-.94,;8.79,-.17,;7.46,-.94,;7.46,-2.48,;6.12,-3.25,;6.12,-4.79,;4.88,-5.7,;5.36,-7.16,;6.9,-7.17,;7.98,-8.25,;7.37,-5.7,;8.79,-3.25,;10.13,-2.48,)| InChI=1S/C18H23N3O2/c1-21(2)14-7-12(8-14)16-9-19-17-4-3-11(6-15(16)17)5-13-10-23-18(22)20-13/h3-4,6,9,12-14,19H,5,7-8,10H2,1-2H3,(H,20,22) JLDUTSKKXXJGGG-UHFFFAOYSA-N 50473503 CHEMBL2110300 5-hydroxytryptamine receptor 1D Homo sapiens 89 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473503 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473503&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 18366015 433940768 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155361 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC3COC(=O)N3)cc12 |wU:3.2,wD:5.7,(12.22,-9.08,;13.25,-7.93,;14.76,-8.24,;12.76,-6.47,;11.38,-5.77,;12.08,-4.41,;13.46,-5.09,;11.59,-2.95,;12.5,-1.69,;11.59,-.45,;10.13,-.94,;8.79,-.17,;7.46,-.94,;7.46,-2.48,;6.12,-3.25,;6.12,-4.79,;4.88,-5.7,;5.36,-7.16,;6.9,-7.17,;7.98,-8.25,;7.37,-5.7,;8.79,-3.25,;10.13,-2.48,)| InChI=1S/C18H23N3O2/c1-21(2)14-7-12(8-14)16-9-19-17-4-3-11(6-15(16)17)5-13-10-23-18(22)20-13/h3-4,6,9,12-14,19H,5,7-8,10H2,1-2H3,(H,20,22) JLDUTSKKXXJGGG-UHFFFAOYSA-N 50473503 CHEMBL2110300 5-hydroxytryptamine receptor 1B Homo sapiens 162 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473503 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473503&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 18366015 433940768 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155362 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CN3C(=O)CNC3=O)cc12 |wU:3.2,wD:5.7,(19.43,-9.55,;20.44,-8.4,;21.95,-8.71,;19.97,-6.93,;18.59,-6.25,;19.27,-4.88,;20.66,-5.56,;18.8,-3.41,;19.71,-2.17,;18.78,-.92,;17.33,-1.41,;15.98,-.64,;14.65,-1.41,;14.65,-2.96,;13.32,-3.73,;13.32,-5.25,;12.06,-6.14,;10.76,-5.95,;12.52,-7.63,;14.06,-7.65,;14.56,-6.19,;15.6,-6.14,;15.98,-3.73,;17.33,-2.95,)| InChI=1S/C18H22N4O2/c1-21(2)13-6-12(7-13)15-8-19-16-4-3-11(5-14(15)16)10-22-17(23)9-20-18(22)24/h3-5,8,12-13,19H,6-7,9-10H2,1-2H3,(H,20,24) WXUMLPDMWNWBQA-UHFFFAOYSA-N 50473518 CHEMBL2368258 5-hydroxytryptamine receptor 1B Homo sapiens 6310 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473518 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473518&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 10782381 433940783 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155363 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC3COC(=O)N3C)cc12 |wU:3.2,wD:5.7,(17.55,-9.96,;18.56,-8.8,;20.07,-9.12,;18.08,-7.35,;16.71,-6.66,;17.39,-5.28,;18.77,-5.97,;16.92,-3.83,;17.81,-2.57,;16.9,-1.33,;15.43,-1.82,;14.1,-1.05,;12.77,-1.83,;12.77,-3.37,;11.43,-4.14,;11.43,-5.68,;10.2,-6.58,;10.67,-8.05,;12.21,-8.05,;13.3,-9.13,;12.68,-6.58,;14.22,-6.58,;14.1,-4.14,;15.45,-3.36,)| InChI=1S/C19H25N3O2/c1-21(2)14-8-13(9-14)17-10-20-18-5-4-12(7-16(17)18)6-15-11-24-19(23)22(15)3/h4-5,7,10,13-15,20H,6,8-9,11H2,1-3H3 SLYXECCOYYLQHN-UHFFFAOYSA-N 50473509 CHEMBL2368257 5-hydroxytryptamine receptor 1B Homo sapiens 98 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473509 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473509&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 18691565 433940774 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155364 N[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC3COC(=O)N3)cc12 |wU:1.0,wD:3.5,(17.46,-8.49,;16.99,-7.03,;15.61,-6.33,;16.29,-4.97,;17.67,-5.65,;15.82,-3.51,;16.71,-2.25,;15.8,-1.01,;14.33,-1.5,;13,-.73,;11.67,-1.5,;11.67,-3.04,;10.34,-3.81,;10.34,-5.35,;9.1,-6.26,;9.57,-7.71,;11.11,-7.73,;12.2,-8.82,;11.58,-6.26,;13,-3.81,;14.35,-3.04,)| InChI=1S/C16H19N3O2/c17-11-5-10(6-11)14-7-18-15-2-1-9(4-13(14)15)3-12-8-21-16(20)19-12/h1-2,4,7,10-12,18H,3,5-6,8,17H2,(H,19,20) ITXICYVPEAFHQO-UHFFFAOYSA-N 50473516 CHEMBL2110299 5-hydroxytryptamine receptor 1D Homo sapiens 3.6 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473516 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473516&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 18691541 433940781 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155365 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CN3C(=O)CNC3=O)cc12 |wU:3.2,wD:5.7,(19.43,-9.55,;20.44,-8.4,;21.95,-8.71,;19.97,-6.93,;18.59,-6.25,;19.27,-4.88,;20.66,-5.56,;18.8,-3.41,;19.71,-2.17,;18.78,-.92,;17.33,-1.41,;15.98,-.64,;14.65,-1.41,;14.65,-2.96,;13.32,-3.73,;13.32,-5.25,;12.06,-6.14,;10.76,-5.95,;12.52,-7.63,;14.06,-7.65,;14.56,-6.19,;15.6,-6.14,;15.98,-3.73,;17.33,-2.95,)| InChI=1S/C18H22N4O2/c1-21(2)13-6-12(7-13)15-8-19-16-4-3-11(5-14(15)16)10-22-17(23)9-20-18(22)24/h3-5,8,12-13,19H,6-7,9-10H2,1-2H3,(H,20,24) WXUMLPDMWNWBQA-UHFFFAOYSA-N 50473518 CHEMBL2368258 5-hydroxytryptamine receptor 1D Homo sapiens 2455 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473518 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473518&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 10782381 433940783 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155366 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(cc12)-c1nc(C)no1 |wU:5.7,wD:3.2,(14.71,-10.01,;15.74,-8.86,;17.26,-9.17,;15.25,-7.4,;15.95,-6.02,;14.57,-5.34,;13.88,-6.71,;14.09,-3.88,;14.99,-2.63,;14.09,-1.38,;12.62,-1.87,;11.29,-1.1,;9.96,-1.89,;9.96,-3.43,;11.29,-4.2,;12.62,-3.41,;8.63,-4.2,;7.14,-3.75,;6.28,-5.03,;4.74,-5.07,;7.21,-6.25,;8.68,-5.73,)| InChI=1S/C17H20N4O/c1-10-19-17(22-20-10)11-4-5-16-14(8-11)15(9-18-16)12-6-13(7-12)21(2)3/h4-5,8-9,12-13,18H,6-7H2,1-3H3 HEQLIAISDLRAIG-UHFFFAOYSA-N 50473519 CHEMBL350637 5-hydroxytryptamine receptor 1D Homo sapiens 562 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473519 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473519&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 10709057 433940784 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155367 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC3COC(=O)N3)cc12 |wU:3.2,wD:5.7,(12.22,-9.08,;13.25,-7.93,;14.76,-8.24,;12.76,-6.47,;11.38,-5.77,;12.08,-4.41,;13.46,-5.09,;11.59,-2.95,;12.5,-1.69,;11.59,-.45,;10.13,-.94,;8.79,-.17,;7.46,-.94,;7.46,-2.48,;6.12,-3.25,;6.12,-4.79,;4.88,-5.7,;5.36,-7.16,;6.9,-7.17,;7.98,-8.25,;7.37,-5.7,;8.79,-3.25,;10.13,-2.48,)| InChI=1S/C18H23N3O2/c1-21(2)14-7-12(8-14)16-9-19-17-4-3-11(6-15(16)17)5-13-10-23-18(22)20-13/h3-4,6,9,12-14,19H,5,7-8,10H2,1-2H3,(H,20,22) JLDUTSKKXXJGGG-UHFFFAOYSA-N 50473503 CHEMBL2110300 5-hydroxytryptamine receptor 1B Homo sapiens 162 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473503 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473503&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 18366015 433940768 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155368 N[C@H]1C[C@@H](C1)c1c[nH]c2ccc(Oc3ccccc3)cc12 |wU:1.0,wD:3.5,(12.4,-12.84,;11.92,-11.37,;10.55,-10.69,;11.23,-9.32,;12.61,-9.99,;10.76,-7.85,;11.65,-6.6,;10.74,-5.35,;9.27,-5.84,;7.94,-5.07,;6.61,-5.86,;6.61,-7.4,;5.27,-8.17,;5.27,-9.71,;6.6,-10.46,;6.61,-12,;5.27,-12.79,;3.93,-12,;3.94,-10.46,;7.94,-8.17,;9.29,-7.38,)| InChI=1S/C18H18N2O/c19-13-8-12(9-13)17-11-20-18-7-6-15(10-16(17)18)21-14-4-2-1-3-5-14/h1-7,10-13,20H,8-9,19H2 KUJBWNONBWTAMM-UHFFFAOYSA-N 50473512 CHEMBL2368254 5-hydroxytryptamine receptor 1B Homo sapiens 9.5 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473512 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473512&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 10588665 433940777 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155369 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(cc12)-c1nc(C)no1 |wU:5.7,wD:3.2,(14.71,-10.01,;15.74,-8.86,;17.26,-9.17,;15.25,-7.4,;15.95,-6.02,;14.57,-5.34,;13.88,-6.71,;14.09,-3.88,;14.99,-2.63,;14.09,-1.38,;12.62,-1.87,;11.29,-1.1,;9.96,-1.89,;9.96,-3.43,;11.29,-4.2,;12.62,-3.41,;8.63,-4.2,;7.14,-3.75,;6.28,-5.03,;4.74,-5.07,;7.21,-6.25,;8.68,-5.73,)| InChI=1S/C17H20N4O/c1-10-19-17(22-20-10)11-4-5-16-14(8-11)15(9-18-16)12-6-13(7-12)21(2)3/h4-5,8-9,12-13,18H,6-7H2,1-3H3 HEQLIAISDLRAIG-UHFFFAOYSA-N 50473519 CHEMBL350637 5-hydroxytryptamine receptor 1B Homo sapiens 832 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473519 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473519&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 10709057 433940784 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155370 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CCN3C(=O)c4ccccc4C3=O)cc12 |wU:3.2,wD:5.7,(14.1,-12.47,;15.13,-11.32,;16.64,-11.63,;14.64,-9.85,;13.26,-9.15,;13.96,-7.79,;15.34,-8.48,;13.47,-6.33,;14.38,-5.07,;13.46,-3.83,;12,-4.32,;10.66,-3.55,;9.33,-4.32,;9.33,-5.86,;7.99,-6.63,;7.99,-8.17,;6.66,-8.94,;6.49,-10.48,;7.64,-11.51,;4.99,-10.8,;4.23,-12.12,;2.69,-12.13,;1.92,-10.79,;2.69,-9.46,;4.23,-9.47,;5.26,-8.31,;4.93,-6.82,;10.66,-6.63,;12,-5.86,)| InChI=1S/C24H25N3O2/c1-26(2)17-12-16(13-17)21-14-25-22-8-7-15(11-20(21)22)9-10-27-23(28)18-5-3-4-6-19(18)24(27)29/h3-8,11,14,16-17,25H,9-10,12-13H2,1-2H3 DMYDUXUHAJAUDX-UHFFFAOYSA-N 50473510 CHEMBL2368261 5-hydroxytryptamine receptor 1D Homo sapiens 195 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473510 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473510&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 10643940 433940775 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155371 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC(=O)NCc3ccccc3)cc12 |wU:5.7,wD:3.2,(10.69,-8.83,;11.7,-7.68,;13.21,-7.99,;11.22,-6.21,;11.91,-4.84,;10.53,-4.15,;9.85,-5.53,;10.06,-2.69,;10.95,-1.45,;10.04,-.19,;8.57,-.68,;7.24,.09,;5.91,-.7,;5.91,-2.24,;4.56,-3.01,;4.56,-4.55,;5.91,-5.32,;3.24,-5.32,;3.24,-6.86,;1.9,-7.63,;1.91,-9.15,;.58,-9.92,;-.76,-9.15,;-.76,-7.59,;.57,-6.84,;7.24,-3.01,;8.59,-2.22,)| InChI=1S/C23H27N3O/c1-26(2)19-12-18(13-19)21-15-24-22-9-8-17(10-20(21)22)11-23(27)25-14-16-6-4-3-5-7-16/h3-10,15,18-19,24H,11-14H2,1-2H3,(H,25,27) HAELKXOQQMRYKK-UHFFFAOYSA-N 50473513 CHEMBL350277 5-hydroxytryptamine receptor 1D Homo sapiens 339 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473513 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473513&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 10546537 433940778 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155372 CNS(=O)(=O)Cc1ccc2[nH]cc([C@H]3C[C@@H](C3)N(C)C)c2c1 |wU:15.17,wD:13.12,(6.67,-10.49,;8,-9.7,;7.98,-8.16,;9.47,-8.56,;6.49,-7.77,;7.98,-6.63,;9.32,-5.86,;9.32,-4.32,;10.65,-3.55,;11.98,-4.32,;13.44,-3.83,;14.36,-5.06,;13.45,-6.32,;13.94,-7.78,;13.24,-9.14,;14.62,-9.84,;15.32,-8.47,;15.11,-11.3,;16.61,-11.61,;14.08,-12.45,;11.98,-5.86,;10.65,-6.63,)| InChI=1S/C16H23N3O2S/c1-17-22(20,21)10-11-4-5-16-14(6-11)15(9-18-16)12-7-13(8-12)19(2)3/h4-6,9,12-13,17-18H,7-8,10H2,1-3H3 KSIPRVBXVOVTDD-UHFFFAOYSA-N 50473520 CHEMBL2368259 5-hydroxytryptamine receptor 1D Homo sapiens 191 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473520 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473520&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 10805740 433940785 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155373 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(cc12)C(N)=O |wU:5.7,wD:3.2,(14.61,-11.78,;15.62,-10.62,;17.13,-10.94,;15.14,-9.17,;15.83,-7.79,;14.45,-7.1,;13.77,-8.47,;13.98,-5.65,;14.87,-4.39,;13.96,-3.15,;12.49,-3.64,;11.16,-2.87,;9.83,-3.64,;9.83,-5.18,;11.16,-5.95,;12.51,-5.18,;8.49,-5.95,;8.49,-7.47,;7.16,-5.18,)| InChI=1S/C15H19N3O/c1-18(2)11-5-10(6-11)13-8-17-14-4-3-9(15(16)19)7-12(13)14/h3-4,7-8,10-11,17H,5-6H2,1-2H3,(H2,16,19) WHLKSQOCYRUNEX-UHFFFAOYSA-N 50473508 CHEMBL158638 5-hydroxytryptamine receptor 1B Homo sapiens 45 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473508 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473508&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 10539089 433940773 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155374 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC3COC(=O)N3C)cc12 |wU:3.2,wD:5.7,(17.55,-9.96,;18.56,-8.8,;20.07,-9.12,;18.08,-7.35,;16.71,-6.66,;17.39,-5.28,;18.77,-5.97,;16.92,-3.83,;17.81,-2.57,;16.9,-1.33,;15.43,-1.82,;14.1,-1.05,;12.77,-1.83,;12.77,-3.37,;11.43,-4.14,;11.43,-5.68,;10.2,-6.58,;10.67,-8.05,;12.21,-8.05,;13.3,-9.13,;12.68,-6.58,;14.22,-6.58,;14.1,-4.14,;15.45,-3.36,)| InChI=1S/C19H25N3O2/c1-21(2)14-8-13(9-14)17-10-20-18-5-4-12(7-16(17)18)6-15-11-24-19(23)22(15)3/h4-5,7,10,13-15,20H,6,8-9,11H2,1-3H3 SLYXECCOYYLQHN-UHFFFAOYSA-N 50473509 CHEMBL2368257 5-hydroxytryptamine receptor 1D Homo sapiens 57.5 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473509 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473509&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 18691565 433940774 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155375 CNS(=O)(=O)Cc1ccc2[nH]cc([C@H]3C[C@@H](C3)N(C)C)c2c1 |wU:15.17,wD:13.12,(6.67,-10.49,;8,-9.7,;7.98,-8.16,;9.47,-8.56,;6.49,-7.77,;7.98,-6.63,;9.32,-5.86,;9.32,-4.32,;10.65,-3.55,;11.98,-4.32,;13.44,-3.83,;14.36,-5.06,;13.45,-6.32,;13.94,-7.78,;13.24,-9.14,;14.62,-9.84,;15.32,-8.47,;15.11,-11.3,;16.61,-11.61,;14.08,-12.45,;11.98,-5.86,;10.65,-6.63,)| InChI=1S/C16H23N3O2S/c1-17-22(20,21)10-11-4-5-16-14(6-11)15(9-18-16)12-7-13(8-12)19(2)3/h4-6,9,12-13,17-18H,7-8,10H2,1-3H3 KSIPRVBXVOVTDD-UHFFFAOYSA-N 50473520 CHEMBL2368259 5-hydroxytryptamine receptor 1B Homo sapiens 275 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473520 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473520&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 10805740 433940785 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155376 [H][C@]1(Cc2c[nH]c3ccc(CS(=O)(=O)NC)cc23)CCCN1C InChI=1S/C16H23N3O2S/c1-17-22(20,21)11-12-5-6-16-15(8-12)13(10-18-16)9-14-4-3-7-19(14)2/h5-6,8,10,14,17-18H,3-4,7,9,11H2,1-2H3 BWQZTHPHLITOOZ-UHFFFAOYSA-N 50473521 CP-122288::CHEMBL159332 5-hydroxytryptamine receptor 1D Homo sapiens 7.2 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473521 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473521&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 132552 433940786 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155377 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC3COC(=O)N3)cc12 |wU:3.2,wD:5.7,(12.22,-9.08,;13.25,-7.93,;14.76,-8.24,;12.76,-6.47,;11.38,-5.77,;12.08,-4.41,;13.46,-5.09,;11.59,-2.95,;12.5,-1.69,;11.59,-.45,;10.13,-.94,;8.79,-.17,;7.46,-.94,;7.46,-2.48,;6.12,-3.25,;6.12,-4.79,;4.88,-5.7,;5.36,-7.16,;6.9,-7.17,;7.98,-8.25,;7.37,-5.7,;8.79,-3.25,;10.13,-2.48,)| InChI=1S/C18H23N3O2/c1-21(2)14-7-12(8-14)16-9-19-17-4-3-11(6-15(16)17)5-13-10-23-18(22)20-13/h3-4,6,9,12-14,19H,5,7-8,10H2,1-2H3,(H,20,22) JLDUTSKKXXJGGG-UHFFFAOYSA-N 50473503 CHEMBL2110300 5-hydroxytryptamine receptor 2C Homo sapiens >10000 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473503 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3430&target=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473503&enzyme=5-hydroxytryptamine+receptor+2C&column=ki&startPg=0&Increment=50&submit=Search 18366015 433940768 1 MVNLRNAVHSFLVHLIGLLVWQSDISVSPVAAIVTDIFNTSDGGRFKFPDGVQNWPALSIVIIIIMTIGGNILVIMAVSMEKKLHNATNYFLMSLAIADMLVGLLVMPLSLLAILYDYVWPLPRYLCPVWISLDVLFSTASIMHLCAISLDRYVAIRNPIEHSRFNSRTKAIMKIAIVWAISIGVSVPIPVIGLRDEEKVFVNNTTCVLNDPNFVLIGSFVAFFIPLTIMVITYCLTIYVLRRQALMLLHGHTEEPPGLSLDFLKCCKRNTAEEENSANPNQDQNARRRKKKERRPRGTMQAINNERKASKVLGIVFFVFLIMWCPFFITNILSVLCEKSCNQKLMEKLLNVFVWIGYVCSGINPLVYTLFNKIYRRAFSNYLRCNYKVEKKPPVRQIPRVAATALSGRELNVNIYRHTNEPVIEKASDNEPGIEMQVENLELPVNPSSVVSERISSV 8DPI,8DPH 5-hydroxytryptamine receptor 2C 5HT2C_HUMAN P28335 B1AMW4 Q5VUF8 Q9NP28 51155378 CN[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC3COC(=O)N3)cc12 |wU:2.1,wD:4.6,(17.04,-8.2,;15.54,-7.89,;15.06,-6.42,;13.68,-5.72,;14.37,-4.36,;15.75,-5.05,;13.89,-2.9,;14.79,-1.64,;13.87,-.4,;12.41,-.89,;11.07,-.12,;9.74,-.89,;9.74,-2.43,;8.41,-3.2,;8.41,-4.74,;7.17,-5.65,;7.64,-7.12,;9.18,-7.12,;10.27,-8.21,;9.66,-5.65,;11.07,-3.2,;12.42,-2.43,)| InChI=1S/C17H21N3O2/c1-18-12-6-11(7-12)15-8-19-16-3-2-10(5-14(15)16)4-13-9-22-17(21)20-13/h2-3,5,8,11-13,18-19H,4,6-7,9H2,1H3,(H,20,21) VHUSWFDFXAXWRN-UHFFFAOYSA-N 50473505 CHEMBL2368256 5-hydroxytryptamine receptor 1B Homo sapiens 32 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473505 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473505&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 18691566 433940770 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155379 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC(N)=O)cc12 |wU:5.7,wD:3.2,(12.37,-11.41,;10.85,-11.09,;9.83,-12.25,;10.37,-9.64,;11.06,-8.26,;9.68,-7.57,;8.99,-8.94,;9.2,-6.11,;10.1,-4.85,;9.19,-3.62,;7.72,-4.11,;6.39,-3.34,;5.06,-4.11,;5.06,-5.65,;3.72,-6.42,;3.72,-7.94,;2.39,-8.73,;5.06,-8.73,;6.39,-6.42,;7.73,-5.65,)| InChI=1S/C16H21N3O/c1-19(2)12-7-11(8-12)14-9-18-15-4-3-10(5-13(14)15)6-16(17)20/h3-5,9,11-12,18H,6-8H2,1-2H3,(H2,17,20) ABNIHDGJNQLJKY-UHFFFAOYSA-N 50473517 CHEMBL348811 5-hydroxytryptamine receptor 1D Homo sapiens 724 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473517 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473517&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 10612178 433940782 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155380 CN(C)[C@H]1C[C@H](Cc2c[nH]c3ccc(C[C@H]4COC(=O)N4)cc23)C1 |wU:3.2,wD:5.5,15.14,(19.87,-5.25,;19.38,-3.78,;20.41,-2.63,;17.88,-3.47,;16.6,-4.31,;15.76,-3.03,;14.25,-2.71,;13.76,-1.26,;14.67,-.01,;13.75,1.24,;12.29,.75,;10.96,1.52,;9.63,.74,;9.63,-.8,;8.28,-1.57,;8.28,-3.11,;7.05,-4.01,;7.53,-5.48,;9.07,-5.48,;10.15,-6.56,;9.54,-4.01,;10.96,-1.57,;12.29,-.79,;17.04,-2.18,)| InChI=1S/C19H25N3O2/c1-22(2)16-7-13(8-16)5-14-10-20-18-4-3-12(9-17(14)18)6-15-11-24-19(23)21-15/h3-4,9-10,13,15-16,20H,5-8,11H2,1-2H3,(H,21,23) OAEYRCBANJKSPM-UHFFFAOYSA-N 50473504 CHEMBL3084967 5-hydroxytryptamine receptor 1D Homo sapiens 29 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473504 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3428&target=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473504&enzyme=5-hydroxytryptamine+receptor+1D&column=ki&startPg=0&Increment=50&submit=Search 10592324 433940769 1 MSPLNQSAEGLPQEASNRSLNATETSEAWDPRTLQALKISLAVVLSVITLATVLSNAFVLTTILLTRKLHTPANYLIGSLATTDLLVSILVMPISIAYTITHTWNFGQILCDIWLSSDITCCTASILHLCVIALDRYWAITDALEYSKRRTAGHAATMIAIVWAISICISIPPLFWRQAKAQEEMSDCLVNTSQISYTIYSTCGAFYIPSVLLIILYGRIYRAARNRILNPPSLYGKRFTTAHLITGSAGSSLCSLNSSLHEGHSHSAGSPLFFNHVKIKLADSALERKRISAARERKATKILGIILGAFIICWLPFFVVSLVLPICRDSCWIHPALFDFFTWLGYLNSLINPIIYTVFNEEFRQAFQKIVPFRKAS 5-hydroxytryptamine receptor 1D 5HT1D_HUMAN P28221 51155381 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(CC3COC(=O)N3)cc12 |wU:3.2,wD:5.7,(12.22,-9.08,;13.25,-7.93,;14.76,-8.24,;12.76,-6.47,;11.38,-5.77,;12.08,-4.41,;13.46,-5.09,;11.59,-2.95,;12.5,-1.69,;11.59,-.45,;10.13,-.94,;8.79,-.17,;7.46,-.94,;7.46,-2.48,;6.12,-3.25,;6.12,-4.79,;4.88,-5.7,;5.36,-7.16,;6.9,-7.17,;7.98,-8.25,;7.37,-5.7,;8.79,-3.25,;10.13,-2.48,)| InChI=1S/C18H23N3O2/c1-21(2)14-7-12(8-14)16-9-19-17-4-3-11(6-15(16)17)5-13-10-23-18(22)20-13/h3-4,6,9,12-14,19H,5,7-8,10H2,1-2H3,(H,20,22) JLDUTSKKXXJGGG-UHFFFAOYSA-N 50473503 CHEMBL2110300 5-hydroxytryptamine receptor 2A Homo sapiens >10000 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473503 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=687&target=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473503&enzyme=5-hydroxytryptamine+receptor+2A&column=ki&startPg=0&Increment=50&submit=Search 18366015 433940768 1 MDILCEENTSLSSTTNSLMQLNDDTRLYSNDFNSGEANTSDAFNWTVDSENRTNLSCEGCLSPSCLSLLHLQEKNWSALLTAVVIILTIAGNILVIMAVSLEKKLQNATNYFLMSLAIADMLLGFLVMPVSMLTILYGYRWPLPSKLCAVWIYLDVLFSTASIMHLCAISLDRYVAIQNPIHHSRFNSRTKAFLKIIAVWTISVGISMPIPVFGLQDDSKVFKEGSCLLADDNFVLIGSFVSFFIPLTIMVITYFLTIKSLQKEATLCVSDLGTRAKLASFSFLPQSSLSSEKLFQRSIHREPGSYTGRRTMQSISNEQKACKVLGIVFFLFVVMWCPFFITNIMAVICKESCNEDVIGALLNVFVWIGYLSSAVNPLVYTLFNKTYRSAFSRYIQCQYKENKKPLQLILVNTIPALAYKSSQLQMGQKKNSKQDAKTTDNDCSMVALGKQHSEEASKDNSDGVNEKVSCV 9LLB,9LLA,9LL9,9LL8,9LL7,9ASA,9AS9,9AS8,9AS7,9AS6,9AS5,9AS4,9AS3,9AS2,9AS1,9AS0,9ARZ,9ARY,9ARX,6WHA,8V6U,8UWL,7RAN 5-hydroxytryptamine receptor 2A 5HT2A_HUMAN P28223 B2RAC5 B4DZ79 F5GWE8 Q5T8C0 51155382 [H][C@]1(Cc2c[nH]c3ccc(CS(=O)(=O)NC)cc23)CCCN1C InChI=1S/C16H23N3O2S/c1-17-22(20,21)11-12-5-6-16-15(8-12)13(10-18-16)9-14-4-3-7-19(14)2/h5-6,8,10,14,17-18H,3-4,7,9,11H2,1-2H3 BWQZTHPHLITOOZ-UHFFFAOYSA-N 50473521 CP-122288::CHEMBL159332 5-hydroxytryptamine receptor 1B Homo sapiens 14 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473521 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473521&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 132552 433940786 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155383 CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12 InChI=1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20) ULSDMUVEXKOYBU-UHFFFAOYSA-N 50033383 (S)-4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)oxazolidin-2-one::(S)-4-[3-(2-Dimethylamino-ethyl)-1H-indol-5-ylmethyl]-oxazolidin-2-one::311C90::CHEMBL1185::ZOMIG::ZOMIG-ZMT::ZOLMITRIPTAN 5-hydroxytryptamine receptor 1B Homo sapiens 6.2 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50033383 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50033383&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 60857 103941674 CHEMBL1185 DB00315 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7 51155384 CN(C)[C@H]1C[C@@H](C1)c1c[nH]c2ccc(Cc3n[nH]c(C)n3)cc12 |wU:5.7,wD:3.2,(17.25,-10.91,;15.75,-10.6,;14.73,-11.75,;15.26,-9.14,;15.96,-7.77,;14.59,-7.08,;13.89,-8.46,;14.1,-5.62,;15.01,-4.38,;14.08,-3.13,;12.63,-3.62,;11.29,-2.85,;9.96,-3.63,;9.96,-5.17,;8.62,-5.94,;8.62,-7.46,;9.88,-8.37,;9.4,-9.84,;7.86,-9.84,;6.95,-11.09,;7.39,-8.37,;11.29,-5.94,;12.63,-5.16,)| InChI=1S/C18H23N5/c1-11-20-18(22-21-11)7-12-4-5-17-15(6-12)16(10-19-17)13-8-14(9-13)23(2)3/h4-6,10,13-14,19H,7-9H2,1-3H3,(H,20,21,22) PASVZMRRFAPOKE-UHFFFAOYSA-N 50473511 CHEMBL159536 5-hydroxytryptamine receptor 1B Homo sapiens 3890 ChEMBL 10.1021/jm000956k 10.7270/Q2PC354M 11262079 Jandu, KS; Barrett, V; Brockwell, M; Cambridge, D; Farrant, DR; Foster, C; Giles, H; Glen, RC; Hill, AP; Hobbs, H; Honey, A; Martin, GR; Salmon, J; Smith, D; Woollard, P; Selwood, DL 3/1/2001 8/22/2020 Glaxowellcome http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50473511 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=3427&target=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50473511&enzyme=5-hydroxytryptamine+receptor+1B&column=ki&startPg=0&Increment=50&submit=Search 10852406 433940776 1 MEEPGAQCAPPPPAGSETWVPQANLSSAPSQNCSAKDYIYQDSISLPWKVLLVMLLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASILHLCVIALDRYWAITDAVEYSAKRTPKRAAVMIALVWVFSISISLPPFFWRQAKAEEEVSECVVNTDHILYTVYSTVGAFYFPTLLLIALYGRIYVEARSRILKQTPNRTGKRLTRAQLITDSPGSTSSVTSINSRVPDVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHLAIFDFFTWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTS 5-hydroxytryptamine receptor 1B 5HT1B_HUMAN P28222 Q4VAY7